News archive for June 2006
Showing page 9 of 64
2006-06-05 08:54:54
... the cure rate in postmenopausal women with breast cancer." As well as improving survival, switching to Aromasin cut the risk of cancer spreading by 17% and lowered the rate of tumours appearing in the opposite breast by 44%. Professor Timothy Cooke, a breast cancer specialist at Glasgow Royal Infirmary, said it was possible that two years of treatment with tamoxifen softened up cancer cells, so they were more vulnerable to the effects of aromatase inhibitors. The IES trial was co-ordinated by the charity Cancer Research UK. Professor John Toy, ...
2006-06-05 09:12:36
... com - Study Sparks Controversy Over Breast Cancer Drugs - Health News | Current Health News | Medical News FOX&Friends|Daytime|YourWorld|BigStory|SpecialReport|FOXReport|O'ReillyFactor|Hannity&Colmes|OnTheRecord|WeekendTOPNEWS::BUSINESS::OPINION::TV::RADIO::MARKETPLACE::FOXFAN::SERVICES::VIDEO SEARCH E-MAIL STORY PRINTER FRIENDLY FOXFAN CENTRAL FOXNEWS.COM HOME > HEALTH Study Sparks Controversy Over Breast Cancer Drugs Monday, June 05, 2006 STORIES ATLANTA—Final results from a big study comparing two drugs for preventing breast cancer in ...
2006-06-05 09:27:54
... al, a firm looking to market a generic version of Viagra. When it joined the World Trade Organization in 2001, China agreed to tighten patent protections.
2006-06-05 09:31:14
... al, a firm looking to market a generic version of Viagra. When it joined the World Trade Organization in 2001, China agreed to tighten patent protections.
2006-06-05 09:42:13
... g court has upheld drug giant Pfizer's patent for Viagra, ruling against the country's patent review board in a case considered pivotal for countering piracy of pharmaceuticals. ADVERTISEMENTAn official at the Beijing No. 1 Intermediate People's Court on Monday confirmed the decision but said she could not provide other information. She refused to give her name, which is common practice among Chinese bureaucrats.It was unclear how the patent review board at China's State Intellectual Property Office would react to the decision. Staff at SIPO in ...
2006-06-05 09:44:00
... D., vice president, cancer research and global oncology platform leader for Eli Lilly and Company.Three presentations were made highlighting enzastaurin's potential for additive or synergistic anticancer effects without excessive toxicity in advanced solid tumors including lung, breast, pancreas, and head/neck cancers. The data were gathered from three Phase I studies that combined enzastaurin with Gemzar/cisplatin (abstract #2046), Alimta (abstract #2047) and capecitabine (abstract #2048). Each study showed simila ...
2006-06-05 09:46:00
... ns may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment. Richard Aplenc, M.D., a pediatric oncologist at The Children's Hospital of Philadelphia, reported on a study of childhood cancer survivors in a presentation today at the American Society of Clinical Oncology (ASCO) annual meeting in Atlanta. He led the research, drawing on data from the Childhood Cancer Survivor Study, a long-term national study sponsored by the National Cancer Institute ...
2006-06-05 09:52:37
... immoral about the use of these methods to prevent disease and sufferingProfessor Ian Wilmut, Roslin Institute Professor Wilmut describes how it would be possible to take an embryo affected by an hereditary disease and then remove its stem cells and modify the genetic fault which, left unchecked, would cause a condition such as Huntington's disease or cystic fibrosis . These defect-free cells would then be cloned and used to create a new embryo which was not affected by disease. This would then be implanted and allowed to develop into a baby. 'D ...
2006-06-05 09:55:00
... a role in transporting highly pathogenic avian influenza (HPAI) virus, or bird flu, over long distances. This was among the main conclusions of a two-day international scientific conference called by the UN Food and Agriculture Organization and the World Organisation for Animal Health (OIE). But the conference, attended by over 300 scientists from more than 100 countries also recognized that the virus was mainly spread through poultry trade, both legal and illegal. "Several presentations at the Conference, some supported by recent publications ...
2006-06-05 09:55:00
... osition and Method for Treating Graft-versus-Host Disease." The patent contains 39 claims relating to the composition and methods for treating graft-versus-host disease (GvHD) and, more specifically, to the administration of inhibitors of adenosine deaminase (ADA). In particular, novel formulations of ADA inhibitors such as pentostatin are utilized for suppressing T-lymphocyte mediated immune responses while minimizing systemic toxicity of the drug. "This is SuperGen's first patent relating to the use of Nipent in graft-versus-host disease, and ...
You can suggest a news source.